Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 3, 2010, Pages 655-661

  Sperduto, Paul W ^a   Chao, Samuel T ^b   Sneed, Penny K ^c   Luo, Xianghua ^a   Suh, John ^b   Roberge, David ^d   Bhatt, Amit ^e   Jensen, Ashley W ^f   Brown, Paul D ^f   Shih, Helen ^g   Kirkpatrick, John ^h   Schwer, Amanda ⁱ   Gaspar, Laurie E ⁱ   Fiveash, John B ^j   Chiang, Veronica ^k   Knisely, Jonathan ^k   Sperduto, Christina Maria ^l   Mehta, Minesh ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f MAYO CLINIC   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF COLORADO   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Minneapolis Radiation Oncology   (United States)

more..

Author keywords

Brain metastases; prognosis; radiotherapy; stereotactic radiosurgery

Indexed keywords

BRAIN METASTASES; BRAIN METASTASIS; CELL CARCINOMA; CLINICAL DECISION; HETEROGENEOUS POPULATIONS; INCOMPLETE DATA; INSTITUTIONAL ANALYSIS; MEDIAN SURVIVAL; MULTI VARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; OPTIMAL TREATMENT; PERFORMANCE STATUS; PROGNOSTIC FACTORS; RANDOMIZED TRIAL; RENAL CELL; SMALL-CELL LUNG CANCER; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOMES; UNIVARIATE;

BRAIN; DECISION MAKING; MULTIVARIANT ANALYSIS; PATHOLOGY; PATIENT MONITORING; RADIOTHERAPY;

DIAGNOSIS;

AGE; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; BRAIN SURGERY; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STEREOTACTIC RADIOSURGERY; TREATMENT OUTCOME;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, RENAL CELL; COMBINED MODALITY THERAPY; GASTROINTESTINAL NEOPLASMS; HUMANS; KARNOFSKY PERFORMANCE STATUS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SELECTION BIAS; SKIN NEOPLASMS; SMALL CELL LUNG CARCINOMA; TREATMENT OUTCOME;

EID: 77952567992     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.025     Document Type: Article

References (31)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics 2008. CA Cancer J Clin 58 (2008) 71-96
2. Zimm S., Wampler G.L., Stablein D., et al. Intracerebral metastases in solid-tumor patients: Natural history and results of treatment. Cancer 48 (1981) 384-394
3. Posner J.B. Neurologic complications of cancer (1995), FA Davies, Philadelphia
4. Sperduto P., and Hall W. The cost-effectiveness of alternative treatments for single brain metastases. In: Kondziolka D (ed): Radiosurgery 1995. Basel, Karger 1 (1996) 180-187
5. Mehta M., Noyes W., Craig B., et al. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single brain metastases. Int J Radiat Oncol Biol Phys 39 (1997) 445-454
6. Rutigliano M.J., Lunsford L.D., Kondziolka D., et al. The cost-effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery 37 (1995) 445-455
7. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 (1997) 745-751
8. Gaspar L., Scott C., Murray K., et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47 (2000) 1001-1006
9. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 363 (2004) 1665-1672
10. Sperduto P., Berkey B., Gaspar L.E., et al. A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70 (2008) 510-514
11. Sperduto C.M., Watanabe Y., Mullan J., et al. A validation study of a new prognostic index for patients with brain metastases: The graded prognostic assessment. J Neurosurg 109 (2008) 87-89
12. Sperduto P., Sneed P., Bhatt A., et al. A multi-institutional validation study of a new prognostic index (graded prognostic assessment, GPA) for patients with brain metastases. American Society for Therapeutic Radiology Oncology. [Abstract 111]. Int J Radiat Oncol Biol Phys 72 (2008) S51
13. Golden D.W., Lamborn K.R., McDermott M.W., et al. Prognostic factors and grading systems for overall survival in patients with radiosurgery for brain metastases: Variation by primary site. J Neurosurg 109 (2008) 77-86
14. Komarnicky L.T., Phillips T.L., Martz K., et al. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG 79-16). Int J Radiat Oncol Biol Phys 20 (1991) 53-58
15. Sause W.T., Scott C., Kirsch R., et al. Phase I/II trial of accelerated fractionation in brain metastases, RTOG 85-28. Int J Radiat Oncol Biol Phys 26 (1993) 653-657
16. Phillips T.L., Scott C.B., Leibel S., et al. Results of a randomized comparison of radiotherapy and bromodeoxyuridine to radiotherapy alone for brain metastases: Report of RTOG trial 89-05. Int J Radiat Oncol Biol Phys 33 (1995) 339-348
17. Murray K.J., Scott C., Greenberg H.M., et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastasis: A report of RTOG 9104. Int J Radiat Oncol Biol Phys 39 (1997) 571-574
18. Weissman D.E. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: A review. J Clin Oncol 6 (1988) 543-551
19. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 (1990) 494-500
20. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain. JAMA 280 (1998) 1485-1489
21. Sneed P.K., Suh J.H., Goetsch S.J., et al. A multi-institutional review of radiosurgery alone vs radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53 (2002) 519-526
22. Aoyama H., Shirato H., Tago M., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases, a randomized controlled trial. JAMA 295 (2006) 2483-2491
23. Patchell R.A., Regine W.F., Loeffler J.S., et al. Letter to editor regarding Aoyama H, Shirato H Tago M, et al. Multi-institutional prospective randomized comparison of stereotactic radiosurgery plus upfront whole brain radiation therapy versus stereotactic radiosurgery alone for the treatment of solitary and multiple brain metastases. JAMA 296 (2006) 2089-2090
24. DeAngelis L.M., Delattre J.Y., and Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology 39 (1989) 789-796
25. Meyers C.A., Smith J.A., Bezjak A., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial. J Clin Oncol 22 (2004) 157-165
26. Regine W.F., Scott C., Murray K., et al. Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: An analysis from Radiation Therapy Oncology Group Study 91-04. Int J Radiat Oncol Biol Phys 51 (2001) 711-717
27. Aoyama H., Tago M., Koto N., et al. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68 (2007) 1388-1395
28. Chang E.L., Wefel J.S., Maor M.H., et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 60 (2007) 277-283
29. Li J., Bentzen S.M., Renschler M., et al. Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol 25 (2007) 1260-1266
30. Brown P.D., Asher A.L., and Farace E. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed. Int J Radiat Oncol Biol Phys 70 (2008) 1305-1309
31. Roman D.D., and Sperduto P.W. Neuropsychological effects of cranial radiation: Current knowledge and future directions. Int J Radiat Oncol Biol Phys 31 (1995) 983-998